DEPLOYThe reference layer for physical AI

Deployment

Whoop (5.0 / MG) at Boston

Whoop (founded 2012 in Boston by Will Ahmed) makes a biometric-primary, screen-free wrist band with strain, recovery, and sleep AI, recorded in the new biometric form factor and notable as the purest subscription-only model in the cohort, with no standalone hardware sale and annual memberships of $199, $239, and $359 that bundle the Whoop 5.0 and the Medical Grade Whoop MG launched May 8, 2025. It is the load-bearing verified-versus-claimed exemplar through a clean split on its MG device: its ECG is FDA-cleared via 510(k) K243236 on April 4, 2025 as an over-the-counter ECG classifying atrial fibrillation, sinus rhythm, and low and high heart rate for adults 22 and older, but its Blood Pressure Insights feature is not cleared and drew an FDA Warning Letter dated July 14, 2025, in which the FDA held that daily systolic and diastolic estimates are inherently associated with the diagnosis of hypertension and hypotension, meeting the device definition and requiring premarket clearance Whoop never obtained, warning that an erroneously low or high reading can have significant consequences. Whoop argues the feature is general wellness under the 21st Century Cures Act and refused to remove it after the compliance deadline passed, and as of May 21, 2026 the dispute remains unresolved with the feature still live and the warning letter now anchoring a class-action lawsuit, so the medical-grade branding applies defensibly only to the cleared ECG and not to blood pressure. A valuation correction is worth recording: Whoop is valued at $10.1 billion after a $575 million Series G in March 2026, not the stale roughly $3.6 billion figure from its 2021 Series F. Its clinical-validation posture is mixed and contested, with a real ECG clearance and study but a public regulatory finding against its blood-pressure marketing, and the blood-pressure accuracy and wellness classification, the Healthspan longevity construct, and the proprietary Strain and Recovery metrics are disputed or unverified.

Whoop (5.0 / MG) by Whoop · Catalog entry · 1 source · not yet field-verified


Machine-readable surfaces

Whoop 4.0 / MG aggregate global deployment. Whoop has hundreds of thousands of active subscribers. No site-specific tracking.

Trust tier
Catalog entry · 1 source · not yet field-verified
Last updated
2026-06-07
Model
Whoop (5.0 / MG)
Company
Whoop
Location
Boston
Status
operational
ID
42f20210-aa50-4feb-a8dd-b8f542fd6a00

Sources (1)

  1. https://www.whoop.com/
Methodology: Verified · 1 source (no primary) · last reviewed 2026-06-07

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-06-07

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: biometric

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Whoop (5.0 / MG) at Boston.

Common questions

What is the Whoop (5.0 / MG) deployment at Boston?
Whoop (5.0 / MG), built by Whoop, is recorded as a deployment at Boston on the DEPLOY registry. Whoop operates the deployment directly.
Who operates Whoop (5.0 / MG) at Boston?
Whoop, the manufacturer of Whoop (5.0 / MG), operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
Have there been incidents at the Whoop (5.0 / MG) deployment at Boston?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.